# Swiss corporate financial performance

> Live situation record from CLSTR: https://clstr.news/situations/swiss-corporate-financial-performance
> Updated: 2026-10-01T17:53:02.000Z. Sources: 7. Developments: 2.

In the second half of 2026, Swiss-based companies reported varying financial results. Helvetia Baloise announced an underlying profit of 631.6 million Swiss francs for the first half of 2026, noting that while IFRS net profit was lower due to a 671.7 million Swiss franc amortization of intangible assets from a merger, the integration process is exceeding synergy targets.

During the same period, HBM Healthcare Investments reported a projected profit of approximately 177 million Swiss francs for its first semester of the 2026/27 fiscal year, an increase from 96 million francs the previous year. This growth was largely driven by private equity holdings and valuation increases in biotech firms.

## Timeline

### 2026-10-01: HBM Healthcare reports significant increase in half-year profit

HBM Healthcare Investments expects a first-semester profit of approximately 177 million Swiss francs, driven largely by strong performance in private equity holdings and biotech acquisitions.

2 sources. https://clstr.news/cluster/hbm-healthcare-reports-significant-increase-in-half-year-profit

### 2026-09-17: Helvetia Baloise reports 631.6 million CHF underlying profit for H1 2026

Helvetia Baloise reported 631.6 million CHF in underlying H1 2026 profit, exceeding targets despite a lower IFRS net profit caused by merger-related asset write-downs.

5 sources. https://clstr.news/cluster/helvetia-baloise-reports-strong-h1-2026-profits-and-rapid-merger-integration

---
Cite as: Swiss corporate financial performance. CLSTR, https://clstr.news/situations/swiss-corporate-financial-performance